文献速递技术与安全神经MR

钆沉积与肾源性系统性纤维化:放射科医师入门指南

Gadolinium Deposition and Nephrogenic Systemic Fibrosis: A Radiologist's Primer.
PubMed 文献 · Radiographics · 2019-12-06

本文综述商用钆基对比剂(GBCA)的分类,讨论肾源性系统性纤维化(NSF)及脑内钆沉积与滞留,并更新美国与欧洲最新监管指南。NSF仅见于晚期肾病患者,与较高剂量及特定类型GBCA相关,新发病例近十年下降。除NSF外,钆沉积与滞留尚未证实有健康影响。

要点

  • NSF仅见于晚期肾病患者,与较高剂量及特定类型GBCA相关,新发病例近十年下降。
  • 钆沉积与滞留已知发生于肝和骨,近期脑内沉积发现重新引发GBCA安全性讨论。
  • 除NSF外,钆沉积与滞留尚无证实健康影响;放射科医师应掌握现行指南。

核心结论

  • GBCA总体安全性良好,但需关注NSF与钆组织沉积/滞留两类问题。
  • NSF仅见于晚期肾病患者,与较高剂量及特定类型GBCA相关,新发病例近十年下降。
  • 除NSF外,钆沉积与滞留尚无证实健康影响,放射科医师应学习现行指南以提供最安全高质量诊疗。

研究设计与样本

  • 综述,总结商用GBCA分类、NSF与脑内钆沉积,并更新美国与欧洲监管指南。
  • 原文未报告系统检索范围与纳入文献数量。

关键影像表现/征象

  • NSF表现为皮肤与皮下组织增厚及全身表现,预后差,仅见于晚期肾病患者。
  • 钆沉积与滞留已知发生于肝和骨,近期发现脑内沉积与滞留。

诊断标准与关键数值

  • NSF与较高剂量及特定类型GBCA相关,原文未给出具体阈值或分级标准。
  • 原文未报告敏感度、特异度、AUC等诊断效能数值。

临床应用与阅片要点

  • 放射科医师应学习现行美国与欧洲监管指南,以提供最安全高质量的患者诊疗。
  • 原文未给出具体阅片或报告操作建议。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Gadolinium-based contrast agents (GBCAs) have an excellent safety profile. However, over the last 2 decades, two specific concerns have surfaced. GBCAs are associated with nephrogenic systemic fibrosis (NSF) and tissue retention of gadolinium. NSF is a rare fibrosing disorder with a poor prognosis, which is characterized by skin and subcutaneous thickening as well as systemic manifestations. The disease has been reported exclusively in patients with advanced renal disease, and it is associated with higher doses and specific types of GBCAs. The number of new cases of NSF has fallen over the past decade, presumably because of adherence by health care providers to regulatory guidelines, which continue to evolve. While gadolinium retention has been known to occur in the liver and bones, the relatively recent findings of deposition and retention in the brain have reignited the debate concerning the safety profile of GBCAs. Despite these concerns, there have been no proven health effects related to gadolinium deposition and retention other than NSF. The authors review the different categories of GBCAs available for commercial use, discuss NSF and gadolinium retention in the brain, and provide updates on the latest U.S. and European regulatory guidelines regarding use of these agents. Given the frequency with which GBCAs are used in clinical practice, it is imperative for all radiologists to learn the current guidelines to provide the safest and highest quality of patient care. ©RSNA, 2019.

来源:Radiographics,查看原文。版权归原作者所有。

引用

  1. Mathur M, Jones JR, Weinreb JC, et al. Gadolinium Deposition and Nephrogenic Systemic Fibrosis: A Radiologist's Primer. Radiographics. 2019. PMID: 31809230. doi:10.1148/rg.2020190110

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。